Clinical trials: Systemic Vascular Damage

Systemic Lupus Erythematosus

WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)

• Completed
• Age: All ages
• Observational study

The study is designed to assess the association between steroid exposure and five potentially steroid-related adverse events within a cohort of individuals with systemic lupus erythematosus (SLE).

Trial name

NCT01616472

Testing

Cumulative corticosteroid exposure

Volunteers

1 people

Sponsor

GlaxoSmithKline